# SELEXIPAG
> **ANDA214414** · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2023-10-11
## Drug
- **FDA Application Number:** ANDA214414
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SELEXIPAG
- **Generic name:** Selexipag
- **Active ingredients:** SELEXIPAG
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ALEMBIC
- **First approval:** 2023-10-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214414)
---
*AI Analytics · CC0 1.0*